Circulars

30 April 2020

Health & Safety Notifications

Reference: CIR-2020-00000072

To all health facilities / all health care practitioners in Dubai's private health sector:

Referring to the above subject, DHA notes all health facilities regarding the Circular issued by the MOHAP for information and adhere to what is stated

  • Lifting the Suspension on the Registration Importation Marketing of the Product Glotac 150mg (Ranitidine)
  • Medical device field safety action Prismaflex Control Unit
  • Medical device recalls TM-317 PneumoDart-Pneumothorax needle
  • Recall Pharmaceutical Product Pure L-Carnitine 550mg Tablets 30’ Pack.pdf
  • Up2 Bow _ Arrow Contains hidden drug ingredient

 

 Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Lifting the Suspension on the Registration Importation Marketing of the Product Glotac 150mg (Ranitidine).pdf:

View Document

Medical device field safety action Prismaflex Control Unit.pdf:

View Document

medical device recalls TM-317 PneumoDart-Pneumothorax needle.pdf:

View Document

Recall Pharmaceutical Product Pure L-Carnitine 550mg Tablets 30’ Pack.pdf:

View Document

Up2 Bow _ Arrow Contains hidden drug ingredient.pdf:

View Document